Paola Mejia

Ms. Paola Mejia


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
GVGuillermo Efrén Villar-Juárez
Guillermo Efrén Villar-Juárez
AGAlma Delia Genis-Mendoza
Alma Delia Genis-Mendoza
NMNicolás Ivan Martínez-López
Nicolás Ivan Martínez-López
AOAna Fresán Orellana
Ana Fresán Orellana
Carlos Alfonso Tovilla-ZárateCarlos Alfonso Tovilla-Zárate
Carlos Alfonso Tovilla-Zárate
HNHumberto Nicolini
Humberto Nicolini
Background/Objectives: Emerging evidence suggests that patients suffering from COVID-19 may experience neurocognitive symptoms. Furthermore, other studies indicate a probable association between leukocyte telomere length (LTL) and neurocognitive changes in subjects with post-COVID-19 condition. Our study was designed to determine the correlation between telomere length and cognitive changes in post-COVID-19 subjects. Methods: This study included 256 subjects, categorized based on SARS-CoV-2 infection from 2020 to 2023. In addition, subjects with a psychiatric diagnosis were considered. Moreover, the MoCA and MMSE scales were applied. Telomere length was determined using a polymerase chain reaction, and statistical analysis was employed using ANOVA and X2 tests. Results: We identified a decrease in LTL in individuals with post-COVID-19 conditions compared to those without SARS-CoV-2 infection (p ≤ 0.05). However, no association was found between LTL and cognitive impairment in the subjects post-COVID-19. Conclusions: The findings suggest that LTL is affected by SARS-CoV-2 infection. Nonetheless, this important finding requires further research by monitoring neurological changes in subjects with post-COVID condition.

ESErika Sanchez
Erika Sanchez
HNHumberto Nicolini
Humberto Nicolini
JVJORGE VILLATORO
JORGE VILLATORO
MGMarycarmen Noemi Bustos Gamiño
Marycarmen Noemi Bustos Gamiño
MMMaria Elena Medina-Mora
Maria Elena Medina-Mora
AGAlma Delia Genis-Mendoza
Alma Delia Genis-Mendoza
There is limited information on the prevalence of mental health symptoms among the population of Mexico City. To provide an update and determine the prevalence of symptoms associated with various disorders in the city, a modified version of the “Screener Questionnaire” was used, the same instrument employed in the National Survey on Drug, Alcohol, and Tobacco Use (ENCODAT) 2016–2017. Data were collected at PILARES centers in different boroughs of Mexico City. A total of 868 questionnaires on symptoms of psychiatric disorders and the use of drugs, alcohol, and tobacco were completed. The most frequently reported symptoms were anxiety (52.67%), depression (39.34%), and post-traumatic stress disorder (44.57%). Additionally, results showed alcohol use at 15.1%, followed by tobacco (13.6%) and illicit drug use (6.8%). The prevalence of these symptoms was also compared with data from ENCODAT 2016–2017 to observe changes over the years.

5 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GVGuillermo Efrén Villar-Juárez
Guillermo Efrén Villar-Juárez
AGAlma Delia Genis-Mendoza
Alma Delia Genis-Mendoza
NMNicolás Ivan Martínez-López
Nicolás Ivan Martínez-López
AOAna Fresán Orellana
Ana Fresán Orellana
Carlos Alfonso Tovilla-ZárateCarlos Alfonso Tovilla-Zárate
Carlos Alfonso Tovilla-Zárate
HNHumberto Nicolini
Humberto Nicolini
Emerging evidence suggests that patients suffering from COVID-19 may experience neurocognitive symptoms. Besides, other studies indicate a probable association between leukocyte telomere length (LTL) and neurocognitive changes in subjects with post-COVID-19 condition. Our study was designed to determine the correlation between telomere length and cognitive changes in subjects post-COVID-19. The study included 256 subjects, categorized based on SARS-CoV-2 infection from 2020 to 2023. On the other hand, those subjects who have a psychiatric diagnosis are considered. Besides, the MoCA and MMSE scales were applied. Telomere length was determined using a Polymerase Chain Reaction, and statistical analysis was employed ANOVA and X2 tests. We identified a decrease in LTL in individuals with post-COVID-19 conditions compared to those without SARS-CoV-2 infection (p≤0.05). However, no association was found between LTL and cognitive impairment in subjects post-COVID-19. The findings suggest that LTL is affected by SARS-CoV-2 infection. Nonetheless, this important finding requires further research by monitoring neurological changes in subjects with post-COVID condition.

Verified
Journal Article
Open access
PDF file
PMPaola Mejia
Paola Mejia
AGAlma Delia Genis-Mendoza
Alma Delia Genis-Mendoza
RVRamon Ramírez Villanueva
Ramon Ramírez Villanueva
SRSusana López Ramírez
Susana López Ramírez
RSRafael Guzmán Sánchez
Rafael Guzmán Sánchez
HNHumberto Nicolini
Humberto Nicolini
Neurocognitive disorders (NCD) are neurodegenerative diseases characterized by decline or loss of cognitive functions. Aging and the APOE genotype have been identified as major risk factors. Telomere length (TL) has been proposed as a biomarker of aging, with shorter TL associated with cognitive decline. This study investigated the relationship between TL and the APOE genotype in individuals with cognitive impairments (CIs). A total of 170 participants aged >55 years were included. Cognitive function was assessed using the MMSE and MoCA tests. Relative telomere quantification and APOE genotype were determined by real-time PCR. A significant association was observed between shorter TL and an increased risk of CI (p < 0.001). Although APOE ε4 is a known genetic risk factor, its association with CI was less clear in this study population, as a considerable proportion of ε4 carriers did not present cognitive impairment (p < 0.05). However, ε4 carriers with CI tended to have shorter TL than those with non-cognitive impairment (NCI-SMC). Furthermore, fewer years of education were strongly correlated with higher CI risk (p < 0.0001). Overall, individuals with both shorter telomeres and lower educational levels exhibited the highest risk of CI. APOE ε4 may contribute to telomere shortening.

16 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ESErika Sanchez
Erika Sanchez
HNHumberto Nicolini
Humberto Nicolini
JVJORGE VILLATORO
JORGE VILLATORO
MGMarycarmen Noemi Bustos Gamiño
Marycarmen Noemi Bustos Gamiño
MMMaria Elena Medina-Mora
Maria Elena Medina-Mora
AGAlma Delia Genis-Mendoza
Alma Delia Genis-Mendoza
There is limited information on the prevalence of mental health symptoms among the population of Mexico City. To provide an update and determine the prevalence of symptoms associated with various disorders in the city, a modified version of the “Screener Questionnaire” was used, the same instrument employed in the National Survey on Drug, Alcohol, and Tobacco Use (ENCODAT) 2016–2017. Data were collected at PILARES centers in different boroughs of Mexico City. A total of 868 questionnaires on symptoms of psychiatric disorders and the use of drugs, alcohol, and tobacco were completed. The most frequently reported symptoms were anxiety (52.67%), depression (39.34%), and post-traumatic stress disorder (44.57%). Additionally, results showed alcohol use at 15.1%, followed by tobacco (13.6%) and illicit drug use (6.8%). The prevalence of these symptoms was also compared with data from ENCODAT 2016–2017 to observe changes over the years.

10 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PMPaola Mejia
Paola Mejia
AGAlma Delia Genis-Mendoza
Alma Delia Genis-Mendoza
RVRamon Ramínez Villanueva
Ramon Ramínez Villanueva
SRSusana López Ramírez
Susana López Ramírez
RSRafael Gúzman Sánchez
Rafael Gúzman Sánchez
HNHumberto Nicolini
Humberto Nicolini
Neurocognitive disorders (NCD) are neurodegenerative diseases characterized by decline or loss of cognitive function. Two main risk factors for this condition have been identified: age and the APOE genotype. One of the proposed mechanisms of aging is telomere length (TL), as an association between shorter TL and NCD has been suggested. This study investigated the relationship between TL and the APOE genotype in individuals with neurocognitive impairment (CI). 170 participants aged > 60 years were included. Cognitive function was assessed using MMSE and MoCA tests. Relative telomere quantification and APOE genotyping were performed using RT-PCR. A shorter TL was significantly associated with an increased risk of CI (p < 0.001). The APOE ε4 genotype showed a less significant association, with individuals not carrying the ε4 allele displaying a higher risk of CI (p < 0.05). However, a trend toward shorter TL were observed in individuals carrying the ε4 allele with CI compared to those Non-Cognitive Impairment with subjective memory Complaint. Additionally, the number of years of education was negatively correlated with CI (p < 0.0001). Individuals with shorter TL and fewer years of education demonstrated a higher risk of CI. APOE genotype would be a risk factor for shorter telomeres.